Cart
sales@molnova.com
Bruceoside A
CAS No. 63306-30-9
Bruceoside A( —— )
Catalog No. M31791 CAS No. 63306-30-9
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 328 | In Stock |
|
| 10MG | 487 | In Stock |
|
| 25MG | 791 | In Stock |
|
| 50MG | 1130 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBruceoside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionBruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
-
DescriptionBruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. It significantly inhibited P-388 lymphocytic leukemic cell RNA and protein synthesis in tissue culture.
-
In Vitro——
-
In VivoBruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. Animal Model:Male ICR mice weighing 25.0 ± 5.0 g.Dosage:22.5 mg/kg.Administration:Intragastrically administrated.Result:Reached its highest levels in three hours with a half-life value of 3.99 h.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number63306-30-9
-
Formula Weight682.7
-
Molecular FormulaC32H42O16
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (366.21 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Antiproliferative ag...
Antiproliferative agent-15 is a reagent with anticancer activity. Antiproliferative agent-15 showed antiproliferative activity against human colon cancer (HCT116 and HCT15) and brain cancer (LN-229 and GBM-10).
-
PUMA BH3
PUMA BH3 is a p53 upregulated modulator of apoptosis (PUMA) BH3 domain peptide, acts as a direct activator of Bak, with a Kd of 26 nM.This is a PUMA BH3 domain peptide. PUMA proteins bind Bcl-2, localize to the mitochondria, and induce cytochrome C release and apoptosis in response to p53. PUMA may be a direct mediator of p53-induced apoptosis.
-
(3b,4a,11a,16b)-16,2...
(3b,4a,11a,16b)-16,23,28-Trihydroxy-11-methoxyolean-12-en-3-yl O-6-deoxy-a-L-mannopyranosyl-(1 4)-O-[b-D-glucopyranosyl-(1 6)]-b-D-glucopyranoside
